Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma )
Clinical trial NCT03975270 · UNKNOWN
Trial details
- NCT number
- NCT03975270
- Sponsor
- Shengyu Zhou
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-20
- Primary completion
- 2021-05-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.